Dextrosal-Baby 500ml IV Infusion

Presentation: A sterile intravenous infusion solution in a 500ml PVC (medical grade) bag. Each 100 ml contains Dextrose Monohydrate equivalent to Dextrose Anhydrous BP 5 gm and Sodium Chloride BP 0.225 gm in sterile Water for Injection BP. Manufactured by Orion Infusion Ltd. in Bangladesh.

Indications: Dextrosal-Baby is indicated for:

• Dehydration accompanied by minor sodium chloride deficiency, particularly in infants and children.
• Maintenance and replacement of fluids, electrolytes, and carbohydrates in patients unable to absorb them orally, such as during pre- and postoperative fluid regimens, shock, or accidents, especially in infants and children who require low sodium content.
• Providing dextrose as a nutrient in a suitable environment of sodium chloride.
• Short-term fluid replacement after trauma.
• Combined water and sodium depletion.

Dosage and Administration: The dose is variable and depends on the patient's clinical condition, age, body weight, and the judgment of the physician. Generally, for infants and children, the rate is 60-120 drops per minute intravenously or according to the physician's recommendation. The solution should be administered intravenously by a healthcare professional using sterile equipment. It should be visually inspected for particulate matter and discoloration prior to administration; do not use if cloudy or containing particles.

Side Effects: Reactions that may occur due to the solution or the technique of administration include:

• Febrile response (fever)
• Infection at the site of injection
• Venous thrombosis or phlebitis extending from the site of injection
• Extravasation (leakage of fluid into surrounding tissues)
• Hypervolemia (fluid overload)
• Hyperglycemia (high blood sugar), especially in patients with diabetes
• Electrolyte imbalances
• Hypersensitivity reactions

Precautions:

• Since the preparation contains sodium chloride, it should be used with caution in patients with congestive heart failure, peripheral or pulmonary edema, renal failure, or pre-eclampsia.
• Serum glucose levels should be carefully monitored, and concurrent use of insulin may be necessary in diabetic patients.
• The infusion should be stopped immediately if any adverse reaction occurs.
• Do not use if the solution is cloudy, contains particles, or has expired.
• Use with caution during pregnancy and breastfeeding; consult a healthcare professional before use.
• In very low birth weight infants, excessive or rapid administration of dextrose injection may result in increased serum osmolality and possible hemorrhage. Frequent monitoring of serum glucose concentrations is required in pediatric patients, particularly neonates and low birth weight infants.

Storage: Should be stored at controlled room temperature. Protect from light and moisture. Keep out of reach of children.

Important Note: This information is for general knowledge and informational purposes only, and does not substitute professional medical advice. Always consult your doctor or pharmacist for specific instructions and guidance regarding your medication. They can assess your individual medical condition and provide the most appropriate advice.